MedTrace Logo

Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer

NCT02765698 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2018-03-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate the ability of PET/MRI (Positron Emission Tomography/Magnetic Resonance Imaging) to give physicians preoperative information about specific sites in the body that the endometrial cancer may be present. If the PET/MRI is accurate and successful in providing this information, then women in the future may be able to have less extensive surgery for their endometrial cancer after evaluation with PET/MRI.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Andrea Mariani · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02765698 on ClinicalTrials.gov